Mobile

An Efficacy and Safety Study of Crenezumab in Patients with Prodromal to Mild Alzheimer’s Disease Estudio de Eficacia y Seguridad de Crenezumab en pacientes con Enfermedad de Alzheimer de Prodro...

Update Il y a 4 ans
Reference: EUCTR2016-003288-20

An Efficacy and Safety Study of Crenezumab in Patients with Prodromal to Mild Alzheimer’s Disease Estudio de Eficacia y Seguridad de Crenezumab en pacientes con Enfermedad de Alzheimer de Prodromica a leve

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the efficacy of crenezumab compared with placebo based on change from baseline to Week (W) 105 in global outcomes as assessed by Clinical Dementia Rating-Sum of Boxes (CDR-SB) Evaluar la eficacia de crenezumab en comparación con placebo determinados mediante la CDR-SB, entre el momento basal y la semana 105.

Inclusion criteria

  • Alzheimer's disease,Enfermedad de Alzheimer

Links